![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LSL market cap is 39.57M. The company's latest EPS is CAD -0.1028 and P/E is -4.67.
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Total Revenue | 0 | 10.03M |
Operating Income | -3k | -5.21M |
Net Income | -74k | -8.47M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Total Assets | 25k | 30.9M |
Total Liabilities | 285k | 22.25M |
Total Equity | -260k | 8.66M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Operating | -3k | -7.07M |
Investing | N/A | -1.02M |
Financing | 3k | 8.1M |
Market Cap | 39.57M |
Price to Earnings Ratio | -4.67 |
Price to Sales Ratio | 3.95 |
Price to Cash Ratio | 4.8k |
Price to Book Ratio | 4.57 |
Dividend Yield | - |
Shares Outstanding | 82.44M |
Average Volume (1 week) | 12k |
Average Volume (1 Month) | 14.43k |
52 Week Change | 9.09% |
52 Week High | 0.55 |
52 Week Low | 0.35 |
Spread (Intraday) | 0.01 (1.04%) |
Company Name | LSL Pharma Group Inc |
Address |
540, rue d’avaugour, boucherville quebec city, quebec J4B 0G6 |
Website | https://www.groupelslpharma.com |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions